CTOs on the Move

JeNu Biosciences

www.jenu.com

 
JeNu Biosciences was founded by a leading Washington bio scientist and a medical technology entrepreneur. While working on an ultrasound device for topical drug delivery, they became curious about using ultrasound to improve cosmetic skin care product delivery. High energy ultrasound has been proven effective at pushing drugs through the skin, but in the process cells are damaged and high heat causes intense pain. But since cosmetics only need to be absorbed into the top layer of skin rather than through the skin like drugs they thought a low energy ultrasound device might work. After many attempts they proved that ...
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.jenu.com
  • 1101 N Northlake Way Ste 200
    Seattle, WA USA 98103
  • Phone: 866.565.5368

Executives

Name Title Contact Details

Similar Companies

Cloudbreak Health

Cloudbreak is a language access and telehealth company that has been around for over 16 years. In the course of building out the technology powering our Martti video remote interpretation solution, we developed unparalleled understanding of networks, video traffic, and the technology to enable them.

CareSite Pharmacy

CareSite Pharmacy is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AIDS Services

AIDS Services is a Denton, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Regulatory Presentation Management

Regulatory Presentation Management is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PharmaBlock Sciences

PharmaBlock Sciences (Nanjing), Inc. is a leading innovative chemistry products and services provider throughout the pharmaceutical R&D process. Its core businesses include: a catalog of specially designed scaffolds and building blocks; custom synthesis; process development; manufacturing of key intermediates and RSMs; and FTE services. The company was listed on Shenzhen Exchange Stock in China on November 10, 2017. PharmaBlock has rapidly gained recognition for its outstanding capability in the design, synthesis, and supply of lab scale building blocks. Building on that success, the company acquired Shandong Diai Biotechnology Co., Ltd. as its pilot plant and manufacturing site in 2016, and is providing scale-up synthesis and manufacturing of key intermediates/RSMs. PharmaBlock is now committed to a more comprehensive and long-term service to valued customers.